Back to Search
Start Over
Reprogramming stem cells in regenerative medicine.
- Source :
-
Smart medicine [Smart Med] 2022 Dec 25; Vol. 1 (1), pp. e20220005. Date of Electronic Publication: 2022 Dec 25 (Print Publication: 2022). - Publication Year :
- 2022
-
Abstract
- Induced pluripotent stem cells (iPSCs) that are generated from adult somatic cells are induced to express genes that make them pluripotent through reprogramming techniques. With their unlimited proliferative capacity and multifaceted differentiation potential and circumventing the ethical problems encountered in the application of embryonic stem cells (ESC), iPSCs have a broad application in the fields of cell therapy, drug screening, and disease models and may open up new possibilities for regenerative medicine to treat diseases in the future. In this review, we begin with different reprogramming cell technologies to obtain iPSCs, including biotechnological, chemical, and physical modulation techniques, and present their respective strengths, and limitations, as well as the recent progress of research. Secondly, we review recent research advances in iPSC reprogramming-based regenerative therapies. iPSCs are now widely used to study various clinical diseases of hair follicle defects, myocardial infarction, neurological disorders, liver diseases, and spinal cord injuries. This review focuses on the translational clinical research around iPSCs as well as their potential for growth in the medical field. Finally, we summarize the overall review and look at the potential future of iPSCs in the field of cell therapy as well as tissue regeneration engineering and possible problems. We believe that the advancing iPSC research will help drive long-awaited breakthroughs in cellular therapy.<br />Competing Interests: The authors declare no conflict of interest. Wenguo Cui is a member of the Smart Medicine editorial board.<br /> (© 2022 The Authors. Smart Medicine published by Wiley‐VCH GmbH on behalf of Wenzhou Institute, University of Chinese Academy of Sciences.)
Details
- Language :
- English
- ISSN :
- 2751-1871
- Volume :
- 1
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Smart medicine
- Publication Type :
- Academic Journal
- Accession number :
- 39188749
- Full Text :
- https://doi.org/10.1002/SMMD.20220005